✦ LIBER ✦

Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma

✍ Scribed by Paolo Pedrazzoli; Luisa Ponchio; Carlo Zibera; Gian Antonio Da Prada; Gioacchino Robustelli della Cuna

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 113 KB
Volume: 85
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19990515)85:10<2295::aid-cncr28>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mobilization, collection, and characteri

Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma

✍ Carmelo Bengala; Ilaria Pazzagli; Carmelo Tibaldi; Claudio Favre; Renato Vanacor 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

## Background: As single agents, both paclitaxel and epirubicin in combination with cytokines can mobilize peripheral blood progenitor cells (pbpcs). the authors have demonstrated previously that the combination of epirubicin and paclitaxel is very active against metastatic breast carcinoma and tol

Ifosamide, epirubicin and granulocyte co

Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

✍ M. Arland; S. Leuner; S. Lange; R. Bartsch; C. Kahl; A. Florschütz; A. Franke; H 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract In general, the mobilization of peripheral blood progenitor cells (PBPC) in multiple myeloma (MM) patients is poor and is achieved in most cases by combined cyclophosphamide and G‐CSF. This study was performed to examine the efficacy of combined ifosfamide/epirubicine and G‐CSF for PBPC